Pennington, NJ, United States of America

Jun Shi

USPTO Granted Patents = 19 

 

 

Average Co-Inventor Count = 7.4

ph-index = 3

Forward Citations = 79(Granted Patents)


Location History:

  • Pennington, NJ (US) (2015 - 2023)
  • San Diego, CA (US) (2023)

Company Filing History:


Years Active: 2015-2025

where 'Filed Patents' based on already Granted Patents

19 patents (USPTO):

Title: The Innovative Journey of Jun Shi: Pioneering LPA Antagonists

Introduction:

Jun Shi, a prolific inventor based in Pennington, NJ, has established himself as a leading figure in the field of pharmaceutical innovations. With an impressive portfolio of 14 patents to his name, Jun Shi's groundbreaking work in developing Lysophosphatidic Acid (LPA) antagonists has garnered widespread recognition in the scientific community.

Latest Patents:

Jun Shi's latest patents include the development of Triazole N-linked carbamoyl cyclohexyl acids and Carbamoyloxymethyl triazole cyclohexyl acids as selective LPA receptor inhibitors. These compounds hold immense potential in the treatment of various medical conditions and signify Jun Shi's commitment to advancing therapeutic solutions through novel drug discovery.

Career Highlights:

Having contributed significantly to the pharmaceutical industry, Jun Shi has lent his expertise to renowned companies such as Bristol-Myers Squibb Company and Syngene International Limited. His relentless pursuit of excellence and innovative approach have positioned him as a key player in translating cutting-edge research into practical applications.

Collaborations:

Throughout his career, Jun Shi has collaborated with esteemed professionals, including Yan Shi and Peter Tai Wah Cheng. Together, they have synergized their efforts to push the boundaries of pharmaceutical research and bring forth transformative discoveries that have the potential to improve countless lives.

Conclusion:

In conclusion, Jun Shi's remarkable journey as an inventor underscores his unwavering dedication to technological advancement and scientific innovation. His invaluable contributions to the development of LPA antagonists exemplify his visionary mindset and serve as a testament to his enduring impact on the field of pharmaceuticals. Jun Shi's legacy as a pioneering inventor continues to inspire future generations and shape the landscape of medical research for years to come.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…